SMITH JASON DREW

PrivateCIK: 1821479
Location

PRINCETON, NJ

SMITH JASON DREW (General Counsel) sold 10.5% of their position (1.64K shares) of UROGEN PHARMA LTD. on the open market

Open‑market sale worth $16.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 2 sales
InsiderSMITH JASON DREWCIK 1821479
IssuerUROGEN PHARMA LTD.CIK 1668243
Officer· General Counsel
Since Aug 2020
+58.36K
Net shares
Net buyer
$16.6K
Total sold
2
Open market trades
0B · 2S
8
Total transactions
63.33K acquired · 4.97K disposed
Non-Derivative Transactions4

Ordinary Shares

Direct
M · Option Exercise

Shares

+833.00

Price / share

Trade value

% of position

6.8%
1/31/2023
12.18K13.01K

Ordinary Shares

Direct
S · Sale

Shares

409.00

Price / share

$10.12

Trade value

$4.14K

% of position

3.1%
1/31/2023
13.01K12.60K

Ordinary Shares

Direct
M · Option Exercise

Shares

+2.50K

Price / share

Trade value

% of position

19.8%
1/31/2023
12.60K15.10K

Ordinary Shares

Direct
S · Sale

Shares

1.23K

Price / share

$10.12

Trade value

$12.42K

% of position

8.1%
1/31/2023
15.10K13.87K
Total

Net shares

+1.70K

Net value

-$16.56K

Derivative Transactions4

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Ordinary Shares

833.00 shares

Shares

833.00

Strike price

Held after

834.00

Exercisable

1/31/2023

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Ordinary Shares

2.50K shares

Shares

2.50K

Strike price

Held after

5K

Exercisable

1/31/2023

Restricted Stock Units

Direct
A · Award
Converts to

Ordinary Shares

20K shares

Shares

+20K

Strike price

Held after

20K

Exercisable

1/31/2023

Employee Stock Option (right to buy)

Direct
A · Award
Converts to

Ordinary Shares

40K shares

Shares

+40K

Strike price

10.39

Held after

40K

Exercisable

1/31/2023
SMITH JASON DREW — Insider Transaction (Form 4) Filed Feb 2, 2023 | Finecho